Kei Kunimasa

Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor

Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka et al. · Cancer · 2013 · 178 citations · Full text

Medicine, Molecular Genetics, Oncology +16

The ligand Sas and its receptor PTP10D drive tumour-suppressive cell competition

Masatoshi Yamamoto, Shizue Ohsawa, Kei Kunimasa et al. · Nature · 2017 · 160 citations

Medicine, Cancer Biology, Oncology +10

Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial

Motohiro Tamiya, Akihiro Tamiya, Takako Inoue et al. · PLoS ONE · 2018 · 109 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Complex Mutations in the Epidermal Growth Factor Receptor Gene in Non-small Cell Lung Cancer

Akito Hata, Hiroshige Yoshioka, Shiro Fujita et al. · Journal of Thoracic Oncology · 2010 · 97 citations

Medicine, Genetics, Oncology +12

Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib

Kei Kunimasa, Risa Kamada, Toru Oka et al. · JACC CardioOncology · 2020 · 83 citations · Full text

Medicine, Oncology, Pharmacotherapy +15